网站大量收购闲置独家精品文档,联系QQ:2885784924

Livin蛋白在膀胱移行细胞癌组织芯片中表达及临床意义.doc

Livin蛋白在膀胱移行细胞癌组织芯片中表达及临床意义.doc

  1. 1、本文档共8页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Livin蛋白在膀胱移行细胞癌组织芯片中表达及临床意义

Livin蛋白在膀胱移行细胞癌组织芯片中表达及临床意义[摘要] 目的 探讨Livin蛋白在膀胱移行细胞癌(BTCC)组织芯片中的表达及临床意义。方法 免疫组化S-P法检测70例BTCC组织芯片标本中Livin蛋白的表达,并探讨其与患者的临床病理特征的关系。另选择30例正常的膀胱黏膜组织作对照。结果 BTCC组织中Livin蛋白的阳性率明显高于正常膀胱黏膜组织(χ2=36.51,P<0.01)。BTCC组织中Livin蛋白的表达与肿瘤数量、转移与否、病理分级及临床分期无明显关系(P>0.05),与肿瘤的初发和复发密切相关(P<0.05)。结论 Livin基因参与BTCC的发生、发展和复发过程,可作为BTCC早期诊断和复发风险评估的一项重要指标,有望成为BTCC基因诊断和治疗的新靶点。 [关键词] 膀胱移行细胞癌;组织芯片;免疫组化;Livin;复发 [中图分类号] R737.14 [文献标识码] B [文章编号] 1673-9701(2011)31-88-02 The Expression of Livin Protein in Bladder Transitional Cell Carcinoma Tissue Microarray and Its Clinical Significance XIE Wenjun LI Xiaohong FU Tianhong Department of Pathology,Integrated Chinese and Western Medicine Hospital of Zhejiang Province,Hangzhou 310003,China [Abstract] Objective To investigate the expression of Livin protein in bladder transitional cell carcinoma(BTCC) tissue microarray and its clinical significance. Methods Immunohistochemical SP method was used to detect the expression of Livin protein in 70 cases of BTCC tissue microarray samples and to explore its relationship with clinical pathological features. Another 30 cases of normal bladder mucosal tissues were chosen as the control group. Results The expression of Livin protein in BTCC tissues was significantly higher than that in the normal bladder mucosa(χ2=36.51,P<0.01). There was no significant relationship between the expression of Livin protein in BTCC tissues and the number of tumors,metastasis or not, pathological grade and clinical stage(P>0.05),while it had a close relation with the initiation and recurrence of tumor(P<0.05). Conclusion Livin gene gets involved in the occurrence,development and relapse of BTCC. It can be taken as an important indicator for early diagnosis and recurrence risk assessment of BTCC,and can be expected to become a new gene target for diagnosis and treatment of BTCC. [Key words] Bladder transitional cell carcinoma;Tissue microarray;Immunohistochemistry;Livin;Recurrence 凋亡抑制是肿瘤发生、发展的重要作用机制,凋亡途径的调节紊乱及相关基因

文档评论(0)

linsspace + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档